Physician profile
Mark Elkus
NPI 1366515033
$34,383.61
in general payments reported to CMS, 2019-2025
39 companies · $975 in 2025
The $975 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $9,793 · 2020: $5,912 · 2021: $1,664 · 2022: $432 · 2023: $11K · 2024: $4,158 · 2025: $975.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $12K · Food and Beverage: $2,679 · Travel and Lodging: $2,205.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,700.00 |
| Food and Beverage | $2,678.53 |
| Travel and Lodging | $2,204.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Think Surgical, INC. | $14,363.28 | 2023-2024 | |
| Aesculap Implant Systems, LLC | $13,326.48 | 2019-2021 | |
| Stryker Corporation | $1,943.59 | 2019-2023 | Mako |
| Ethicon INC. | $1,223.09 | 2020-2023 | Dermabond Prineo |
| Depuy Synthes Sales INC. | $681.46 | 2020-2025 | Velys, Healix Knotless Peek, Orthovisc |
| Sanara Medtech INC. | $436.44 | 2020-2025 | Celleraterx, Celleraterx |
| Orthalign INC | $281.35 | 2023-2025 | Orthalign Plus |
| Smith+Nephew, INC. | $248.97 | 2020-2025 | Bone Anchors With Arthroscopic Delivery System, Renasys Touch |
| Ferring Pharmaceuticals INC. | $224.09 | 2019-2022 | |
| Ethicon US, LLC | $202.53 | 2021 | |
| Encore Medical, Lp | $201.30 | 2024 | Djo Surgical |
| Zyla Life Sciences, INC. | $187.74 | 2019-2020 | |
| Innovation Technologies INC | $168.43 | 2022 | |
| Osteoremedies, LLC | $166.12 | 2025 | Blastx, Xperience |
| Zimmer Biomet Holdings, INC. | $83.80 | 2025 |
Show all 39 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pacira Therapeutics, INC. | $53.22 | 2019 | |
| Kci USA, INC. | $48.22 | 2019-2020 | |
| Convatec INC. | $42.65 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $41.57 | 2023-2025 | Relistor |
| Avanos Medical | $35.49 | 2019 | |
| Atland Pharmaceuticals, LLC | $34.02 | 2025 | Orphenadrine Citrate, Aspirin and Caffeine, Tolmetin Sodium |
| Solventum Corporation | $32.13 | 2025 | Prevena |
| Illuminoss Medical, INC. | $31.52 | 2025 | |
| Djo, LLC | $29.21 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $28.46 | 2019-2024 | Zilretta, Iovera, Exparel |
| Medical Device Business Services, INC. | $26.72 | 2021 | |
| Sonex Health, INC. | $26.00 | 2024 | Sx-One Microknife |
| Assertio Therapeutics, INC. | $24.28 | 2019-2020 | |
| Vertex Pharmaceuticals Incorporated | $23.58 | 2025 | |
| Heron Therapeutics, INC. | $22.80 | 2021-2022 | |
| Becton, Dickinson and Company | $20.19 | 2025 | Arista |
| Conmed Corporation | $19.06 | 2025 | Abc Handpieces, Visiclear |
| Heraeus Medical, LLC. | $18.25 | 2024 | |
| Cumberland Pharmaceuticals, INC. | $18.14 | 2019 | |
| Bioventus LLC | $17.21 | 2025 | Exogen Ultrasound Bone Healing System |
| Baudax Bio INC. | $16.25 | 2021 | |
| Molnlycke Health Care US, LLC | $13.50 | 2025 | Mepilex Border Post-Op Ag |
| Janssen Pharmaceuticals, INC | $11.47 | 2021 | |
| Horizon Therapeutics Plc | $11.00 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Elkus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.